Get started
Author

Matina Fragkogianni

Molecular and immune landscape of early-onset versus average-onset well-differentiated enteropancreatic neuroendocrine tumors.
2026 · Udhayvir Singh Grewal, Brooke Rhead, et al. · Journal of Clinical Oncology · 1
Impact of claudin-1 (CLDN1) expression on molecular correlates and clinical outcomes in patients with advanced biliary tract cancers (BTCs).
2026 · Diana L. Hanna, Adam Dugan, et al. · Journal of Clinical Oncology
PDF
Use of transcriptomic signatures of RAD51 and GATA6 to predict real-world overall survival with platinum therapy in BRCA/PALB2 wild-type metastatic pancreatic cancer.
2026 · Binbin Zheng-Lin, Ellen B. Jaeger, et al. · Journal of Clinical Oncology
Multiomic analysis and oncologic outcomes in pancreatic cancer by PIN1 expression.
2026 · Mustafa Raoof, Adam Dugan, et al. · Journal of Clinical Oncology
Molecular characterization of resected non-metastatic pancreatic cancer (PC) based on KRAS status.
2026 · Angelo Pirozzi, Ellen B. Jaeger, et al. · Journal of Clinical Oncology
Genomic profiling of epithelial neoplasms of the appendix: Insights across histological subtypes and histological grades.
2026 · Michael J. Overman, Yingying Yu, et al. · Journal of Clinical Oncology
PDF
Advanced pancreatic adenocarcinoma outcomes in patients with DDR deficiencies outside of BRCA1/2 and PALB2.
2026 · Maria Diab, Brooke Rhead, et al. · Journal of Clinical Oncology
PDF
Abstract P1-03-25: Characterization of the tumor immune microenvironment (TIME) and somatic landscape of metaplastic breast cancer (MpBC)
2025 · Shaveta Vinayak, Lynn Symonds, et al. · Clinical Cancer Research
Abstract 2698: Transcriptional profiling of human TAMs highlights differences in breast and endometrial tumour microenvironments
2016 · Matina Fragkogianni, Luca Cassetta, et al. · Cancer Research
Works count: 9
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type